Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Non-Current Assets of $17.8 billion in Q1 2026, down 1.18% quarter-over-quarter from $18.0 billion in Q4 2025, and up 7.02% on a YoY basis from $16.6 billion in Q1 2025.
Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Non-Current Assets history runs 18 years deep, the most recent figure standing at $17.8 billion for Q1 2026.
- In Q1 2026, Non-Current Assets rose 7.02% year-over-year to $17.8 billion; the TTM figure through Mar 2026 stood at $71.2 billion (up 6.22% YoY), while the FY2025 annual figure was $18.0 billion, up 7.66% from the prior year.
- Non-Current Assets was $17.8 billion for Q1 2026 at Zimmer Biomet Holdings, down from $18.0 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $18.0 billion in Q4 2025 to a low of $16.6 billion in Q1 2025.
- Historically, Non-Current Assets has averaged $17.1 billion across 5 years, with a median of $16.9 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets fell 10.41% in 2022, then rose 7.66% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $16.6 billion in 2022, then climbed by 1.49% to $16.9 billion in 2023, then slipped by 1.15% to $16.7 billion in 2024, then grew by 7.66% to $18.0 billion in 2025, then retreated by 1.18% to $17.8 billion in 2026.
- The last three Non-Current Assets figures came in at $17.8 billion (Q1 2026), $18.0 billion (Q4 2025), and $17.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 17.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.76 Bn |
| Dec 31, 2025 | 17.97 Bn |
| Sep 30, 2025 | 17.65 Bn |
| Jun 30, 2025 | 17.81 Bn |
| Mar 31, 2025 | 16.59 Bn |
| Dec 31, 2024 | 16.69 Bn |
| Sep 30, 2024 | 16.86 Bn |
| Jun 30, 2024 | 16.88 Bn |
| Mar 31, 2024 | 16.82 Bn |
| Dec 31, 2023 | 16.89 Bn |
| Sep 30, 2023 | 16.85 Bn |
| Jun 30, 2023 | 16.91 Bn |
| Mar 31, 2023 | 16.83 Bn |
| Dec 31, 2022 | 16.64 Bn |
| Sep 30, 2022 | 16.80 Bn |
| Jun 30, 2022 | 16.99 Bn |
| Mar 31, 2022 | 17.10 Bn |
| Dec 31, 2021 | 18.57 Bn |
| Sep 30, 2021 | 18.70 Bn |
| Jun 30, 2021 | 18.87 Bn |